154 related articles for article (PubMed ID: 9537649)
1. Role of tumor suppressor genes in transplacental lung carcinogenesis.
Rollins LA; Leone-Kabler S; O'Sullivan MG; Miller MS
Mol Carcinog; 1998 Mar; 21(3):177-84. PubMed ID: 9537649
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
3. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene.
Gressani KM; Rollins LA; Leone-Kabler S; Cline JM; Miller MS
Carcinogenesis; 1998 Jun; 19(6):1045-52. PubMed ID: 9667743
[TBL] [Abstract][Full Text] [Related]
4. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene.
Gressani KM; Leone-Kabler S; O'Sullivan MG; Case LD; Malkinson AM; Miller MS
Carcinogenesis; 1999 Nov; 20(11):2159-65. PubMed ID: 10545420
[TBL] [Abstract][Full Text] [Related]
5. Alterations at the Ink4a locus in transplacentally induced murine lung tumors.
Mizesko MC; Grewe C; Grabner A; Miller MS
Cancer Lett; 2001 Oct; 172(1):59-66. PubMed ID: 11595130
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors.
Leone-Kabler S; Wessner LL; McEntee MF; D'Agostino RB; Miller MS
Carcinogenesis; 1997 Jun; 18(6):1163-8. PubMed ID: 9214598
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.
Miller MS; Gressani KM; Leone-Kabler S; Townsend AJ; Malkinson AM; O'Sullivan MG
Exp Lung Res; 2000 Dec; 26(8):709-30. PubMed ID: 11195466
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
9. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
10. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene.
Wessner LL; Fan M; Schaeffer DO; McEntee MF; Miller MS
Carcinogenesis; 1996 Jul; 17(7):1519-26. PubMed ID: 8706258
[TBL] [Abstract][Full Text] [Related]
11. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
12. Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice.
Cazorla M; Hernández L; Fernández PL; Fabra A; Peinado MA; Dasenbrock C; Tillmann T; Kamino K; Campo E; Kohler M; Morawieltz G; Cardesa A; Tomatis L; Mohr U
Mol Carcinog; 1998 Apr; 21(4):251-60. PubMed ID: 9585255
[TBL] [Abstract][Full Text] [Related]
13. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
14. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
16. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
17. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
18. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice.
Hegi ME; Söderkvist P; Foley JF; Schoonhoven R; Swenberg JA; Kari F; Maronpot R; Anderson MW; Wiseman RW
Carcinogenesis; 1993 May; 14(5):803-10. PubMed ID: 8504472
[TBL] [Abstract][Full Text] [Related]
19. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
[TBL] [Abstract][Full Text] [Related]
20. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
